|
|
||||||||
1 From the Department of Ophthalmology and Visual Sciences, University of Louisville, School of Medicine, Louisville, Kentucky.
| Abstract |
|---|
|
|
|---|
METHODS. RNA from conjunctivae of six donors (3 men, 3 women, 44 to 69 years, all white) was isolated and subjected to competitive reverse transcriptionPCR. Internal standards, which are dsDNA molecules with ends complementary to a given primer pair but containing nonhomologous central sequences, were prepared for each gene assayed. Titration of a constant amount of cDNA against serial dilutions of the internal standard allowed quantification of the template cDNA. MUC2 and MUC5AC levels were compared to levels of the "housekeeping" gene, ß2-microglobulin (ß2M). The identity of PCR products was confirmed by sequencing.
RESULTS. In the six individual samples tested, ß2M mRNA is expressed, on average, at approximately 10-20 moles per sample (1 µg RNA) or approximately 63.5 x 104 molecules. The mRNA encoding MUC5AC, a relatively abundant ocular mucin, exists at levels 10-fold lower than ß2M. In contrast to previous reports of MUC2 mRNA being absent at the ocular surface, these results show that MUC2 transcripts are present and expressed at levels 5900-fold lower than for MUC5AC. Apparently, MUC2 transcripts exist on the order of only approximately 100 to 1000 molecules/µg of RNA in the analyzed samples.
CONCLUSIONS. MUC2 transcripts are present in human conjunctival tissue and their abundance is much lower than that of MUC5AC. This is the first application of competitive PCR to the quantitative analysis of mucin expression in human ocular tissue. The sensitivity of this method allows the detection of MUC2 transcripts that were not detected by Northern blot analysis or in situ hybridization in previous studies. It also makes possible the comparison of relative levels of expression for ocular mucins.
| Introduction |
|---|
|
|
|---|
Mucins comprise a heterogeneous family of glycoproteins expressed by most specialized epithelial tissues of mucosal surfaces. To date, nine distinct mucin genes have been reported (MUC1 to 4, MUC5AC, MUC5B, MUC6 to 8). Historically, expression of these genes was thought to be tissue-specific. However, it appears that many of the mucin genes are expressed in a wide variety of tissues with overlapping patterns of expression.8 9 10 Of these, three have been detected on the ocular surface: MUC1, MUC4 (ASGP-2), and MUC5AC.11 12 13 14 MUC1 and ASGP-2 are membrane-associated mucins produced by nongoblet conjunctival epithelial cells.12 15 16 17 Conjunctival goblet cells are thought to be the major source of the soluble ocular mucin MUC5AC.14 18
Of the known mucins, only MUC2, MUC5AC, and MUC5B are consistently associated with goblet cells. In situ hybridization studies by Inatomi et al.18 show that mRNA for MUC5AC is localized in human conjunctival goblet cells. These authors, using Northern blotting techniques were unable to detect any MUC2 transcripts in normal human conjunctiva. Previously reported studies from our laboratory, using reverse transcriptionpolymerase chain reaction (RT-PCR), a more sensitive technique, clearly demonstrate the presence of MUC2 transcripts in normal human conjunctival tissues.13 The present studies therefore were undertaken to confirm the presence of MUC2 transcripts in human conjunctiva, to quantify the abundance of MUC2 mRNA relative to that of MUC5AC, and to verify the presence of the corresponding secretory product in the normal human tear film.
| Methods |
|---|
|
|
|---|
Human corneal endothelial cells (HCN; Steve Wilson, University of Washington, Seattle, WA) and LS180 cells (ATCC, Manassas, VA) were cultured in HEM (DMEM/F12 containing 10 ng/ml epidermal growth factor, 1 µg/ml insulin, 5% fetal bovine serum, and 1% antibioticantimycotic mix) before extraction of RNA.
Collection of Human Tear Samples
Tear samples were collected as previously
described.14
RNA Isolation
Total RNA was isolated using a guanidinium isothiocyanate protocol
(RNeasy; Qiagen, Santa Clarita, CA). The resultant RNA was treated with
RNase-free DNase, extracted twice with phenol:chloroform:isoamyl
alcohol (24:24:1), precipitated with ethanol, dissolved in RNase-free
water, and quantified spectrophotometrically. Average yields observed
were approximately 1 µg RNA per milligram of tissue (wet weight).
Total RNA from human salivary gland and trachea was used for controls
(Clontech, Palo Alto, CA). Each RNA preparation was characterized
qualitatively by electrophoresis on agarose gels stained with ethidium
bromide.
Competitive RT-PCR
Quantitative analysis of mucin transcripts was carried out by
MIMIC competitive PCR (Clontech). The method is a co-PCR reaction with
target cDNA and a competing exogenous template serving as an internal
standard.19
20
21
The competitive MIMIC template is a dsDNA
construct with ends engineered to be complimentary to the mucin
primers, but containing a nonhomologous central sequence
(v-erbB). Coamplification of a constant amount of
conjunctival cDNA in the presence of serial dilutions of this internal
standard allows for quantification of mucin mRNA.
ß2-Microglobulin (ß2M),
a ubiquitously expressed protein, was used as a "housekeeping gene"
for comparative purposes. After reverse transcription, 1 µl (~1 ng)
of conjunctival cDNA was amplified and analyzed. Primers for both MUC2
and MUC5AC were as previously published.21
Primers for
ß2M were purchased from Clontech. PCR
parameters consisted of an initial denaturation at 94°C for 10
minutes to heat activate the DNA polymerase (Amplitaq Gold; Perkin
Elmer, Foster City, CA). This was followed by 30 cycles of denaturation
at 94°C for 1 minute (40 cycles for MUC2), annealing at 59°C for 1
minute for MUC2 (60°C for MUC5AC, 54°C for
ß2M), and extension at 72°C for 1 minute with
a final extension at 72°C for 7 minutes. MgCl2
was included at 2.5 mM for ß2M and MUC5AC (1.5
mM for MUC2). Identities of PCR products were confirmed by sequencing.
After electrophoresis in 1% agarose, bands corresponding to target
cDNAs and MIMIC competitors were stained with ethidium bromide and
photographed with Polaroid Type 667 film. The photographs were
digitized with an Epson Action Scanner II digital image processor
and analyzed using SigmaGel (Jandel, San Rafael, CA) software. Levels
of mucin and ß2M PCR products were determined by
densitometric analysis and normalized to corresponding MIMIC standards.
Results of MUC2 and MUC5AC amplification were compared to those
obtained from ß2M amplification to determine the relative
abundance of mucin transcripts. Reported numbers of transcripts are
based on the assumption of 100% efficiency of cDNA synthesis although
actual efficiency is lower. Therefore, the estimated transcript numbers
represent the minimum number of mucin-specific mRNAs in the tissue
samples.
SDS-PAGE and Western Blot Analysis
Human conjunctival tissue and tears were prepared in SDS-PAGE
sample buffer. All samples and standards were boiled for 5 minutes
before loading onto 4% to 15% polyacrylamide gradient gels (Bio-Rad,
Hercules, CA). Gels were run for 1 hour at 200 mV, washed in transfer
buffer, and electroblotted onto nitrocellulose membranes for 1 hour at
100 mV. Blots were blocked overnight at 4°C with TTBS containing 2%
ovalbumin and then incubated with the anti-MUC antisera at 1:1000 or
with the corresponding normal serum at the same dilution. After three
rinses, blots were incubated with horseradish peroxidaseconjugated
rabbit anti-mouse IgG (1:5000) for 1 hour and developed using a
chemiluminescent substrate (Dupont NEN, Boston, MA). The MUC1 antibody
(DF3) was purchased from Signet (Dedham, MA). The MUC2 antibody, 4F1,
is a kind gift of Shirley Bolis, Peter Devine, and Carol Morris,
University of Queensland. The MUC5AC antibody was prepared and
characterized as described previously.14
| Results |
|---|
|
|
|---|
|
Quantification of Mucin Transcripts by Competitive RT-PCR
A competitive RT-PCR method (MIMIC; Clontech) was used to
determine levels of MUC2, MUC5AC, and ß2M
transcripts in conjunctival samples from six donors. For results of the
competitive amplification to be valid, both the competing MIMIC
template and the target cDNA must amplify with comparable efficiencies.
Target cDNA and MIMIC template were amplified independently, and levels
of PCR products were visualized on ethidium bromidestained agarose
gels. The number of cycles and starting amounts of MIMIC template were
determined empirically such that, after amplification, levels of target
cDNA products and MIMIC products were comparable. Both cDNA and MIMIC
templates for the two mucins, MUC2 and MUC5AC, and for
ß2M, amplify with comparable efficiencies. This
can be seen in Figure 2
, as cDNA- and MIMIC-amplified products increase in parallel as the cycle
number increases.
|
|
|
Presence of MUC2 Glycoprotein in Human Conjunctiva and Tears
To determine whether the MUC2 protein is present in normal human
conjunctival tissue and in tears, samples were analyzed by Western
blotting (Fig. 4)
. Two other mucins were analyzed as positive controls: MUC1, a
transmembrane mucin expressed in conjunctiva,29
and
MUC5AC, shown by previous studies in our laboratory to be present in
conjunctiva and tears.14
Western blot analysis showed that
all three mucin antibodies bind high-molecular-mass components in
conjunctival samples. The MUC1 antibody (Ab) did not bind to any
soluble high-molecular-mass component in tears, consistent with MUC1s
role as a transmembrane molecule. Antibodies for MUC2 and MUC5AC bound
specifically to high-molecular-weight components of tears.
|
| Discussion |
|---|
|
|
|---|
Transcripts of MUC1, MUC4, and MUC5AC have been identified in normal human conjunctiva. We now add MUC2 as a component of the conjunctival mucin profile. MUC2 is transcribed in human conjunctival tissue, and its corresponding protein is present in the tear film. The application of competitive PCR to the quantitative analysis of MUC2 and MUC5AC expression in ocular tissue demonstrates the relatively low abundance of MUC2. The sensitivity of this method allows the detection of transcripts for MUC2, which have not been detected by either Northern blot analysis or in situ hybridization. It also has made possible the comparison of relative levels of ocular mucin transcripts.
Although both MUC2 and MUC5AC transcripts are expressed in the normal human conjunctiva, levels of MUC2 mRNA are considerably lower than those of MUC5AC. Of the individuals tested, MUC5AC levels exceed those of MUC2 by 24-fold (subject 6, highest MUC2 level observed) to 3 x 104-fold (subject 2, lowest MUC2 level and highest MUC5AC level observed). On average, the MUC5AC values exceed MUC2 levels by 5.9 x 103-fold. Interestingly, men in the study express higher levels of MUC2 than do women. The mean level of MUC2 for men (807 transcripts per microgram of RNA) exceeds that of women (mean value of 38 transcripts per microgram of RNA) by 21-fold. Normalized MUC2 values show the same trenda 17-fold difference between men and women. For MUC5AC, women show slightly higher levels than men (3.2-fold difference for nonnormalized values and 7.9-fold difference for normalized values). Admittedly, the sample size is small, and further testing is needed to determine whether the observed gender differences extend to protein expression and are representative of the normal population.
It is possible that transcripts from different mucin genes differ in stability. This could lead to artifactual differences in mRNA expression levels in postmortem tissue. However, given the magnitude of the difference (5.9 x 103-fold) between MUC2 and MUC5AC transcript levels, it is unlikely that it is a result of differential stability. Additionally, as partially degraded transcripts can be amplified by RT-PCR, it is even less likely that differential stability is involved.
Previous studies in our laboratory have shown that MUC5AC glycoprotein is readily detectable in the normal human tear film. This study demonstrates, by Western blot analysis, the presence of MUC2 protein in conjunctival tissue and in tears. An immunoreactive band of high molecular mass (>210 kDa) was detected as well as smaller bands that likely represent MUC2 variants, degradation products, or artifacts of sample preparation. The increased levels of these smaller bands in tears suggest that they may be products of protein degradation by proteinases contained in the tear film.
We are currently investigating the hypothesis that MUC2 is expressed in a subset of conjunctival goblet cells. In a developmental study of respiratory tract mucins, Buisine et al.31 noted that MUC2 expression precedes that of MUC5AC and is present in differentiating cells, but only in a subset of mature goblet cells. As goblet cells of the conjunctiva apparently arise from precursors localized in the fornix, we predict that this region may be the source of conjunctival MUC2. It is of interest to note that the tissues used in the present study for mRNA isolation included both fornical and bulbar conjunctiva. Little is known about possible mechanisms governing MUC2 secretion. MUC5AC secretion is stimulated by adenine nucleotides via P2Y2 receptors.32 Because MUC2, like MUC5AC is considered a goblet cell mucin, we hypothesize that its secretion, too, may be triggered by activation of P2Y2 receptors.
As RT-PCR becomes more widely applied to detection of mucin transcripts in ocular tissues, it is likely that mucins previously thought not to exist at the ocular surface will be identified. Previous reports by Inatomi and associates18 indicated that of mucins 2 through 7, only MUC4 and MUC5AC are present in human conjunctiva. Northern blot analysis of these mucins showed positive signals for MUC4 and MUC5AC. MUC7 showed a positive signal only after extended exposure. Further analysis by in situ hybridization indicated the presence of MUC4 in stratified conjunctival epithelium and MUC5AC in conjunctival goblet cells. MUC7 was not detected. However, the more sensitive RT-PCR method is capable of detecting fewer than 10 transcripts in a sample. Using this method, we have detected both MUC2 (present results) and more recently, MUC7 (unpublished data) in human conjunctiva. We are currently testing for presence of additional mucin transcripts and secreted mucin proteins in human conjunctiva and in tears.
As additional mucins are identified on the ocular surface, it is becoming clear that the mucin profile in the tear film is complex. Analysis of the cellular sources and functional contributions of individual tear film mucins are the ongoing goals of our studies.
| Acknowledgements |
|---|
| Footnotes |
|---|
Submitted for publication June 16, 1999; revised September 1 and October 12, 1999; accepted October 27, 1999.
Commercial relationships policy: N.
Corresponding author: Marcia M. Jumblatt, Department of Ophthalmology and Visual Sciences, University of Louisville School of Medicine, Louisville, KY 40292. mmjumb01{at}athena.louisville.edu
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
N. Dong, W. Li, H. Lin, H. Wu, C. Li, W. Chen, W. Qin, L. Quyang, H. Wang, and Z. Liu Abnormal Epithelial Differentiation and Tear Film Alteration in Pinguecula Invest. Ophthalmol. Vis. Sci., June 1, 2009; 50(6): 2710 - 2715. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. K. Gipson The Ocular Surface: The Challenge to Enable and Protect Vision: The Friedenwald Lecture Invest. Ophthalmol. Vis. Sci., October 1, 2007; 48(10): 4391 - 4398. [Full Text] [PDF] |
||||
![]() |
A. N. Round, T. J. McMaster, M. J. Miles, A. P. Corfield, and M. Berry The isolated MUC5AC gene product from human ocular mucin displays intramolecular conformational heterogeneity Glycobiology, June 1, 2007; 17(6): 578 - 585. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Tanioka, S. Kawasaki, K. Yamasaki, L. P. K. Ang, N. Koizumi, T. Nakamura, N. Yokoi, A. Komuro, T. Inatomi, and S. Kinoshita Establishment of a cultivated human conjunctival epithelium as an alternative tissue source for autologous corneal epithelial transplantation. Invest. Ophthalmol. Vis. Sci., September 1, 2006; 47(9): 3820 - 3827. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. I. Koufakis, C. H. Karabatsas, L. I. Sakkas, A. Alvanou, A. K. Manthos, and D. Z. Chatzoulis Conjunctival Surface Changes in Patients with Sjogren's Syndrome: A Transmission Electron Microscopy Study Invest. Ophthalmol. Vis. Sci., February 1, 2006; 47(2): 541 - 544. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Berry, R B Ellingham, and A P Corfield Human preocular mucins reflect changes in surface physiology Br J Ophthalmol, March 1, 2004; 88(3): 377 - 383. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Diebold, M. Calonge, A. E. de Salamanca, S. Callejo, R. M. Corrales, V. Saez, K. F. Siemasko, and M. E. Stern Characterization of a Spontaneously Immortalized Cell Line (IOBA-NHC) from Normal Human Conjunctiva Invest. Ophthalmol. Vis. Sci., October 1, 2003; 44(10): 4263 - 4274. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Chen, P. Thai, Y.-H. Zhao, Y.-S. Ho, M. M. DeSouza, and R. Wu Stimulation of Airway Mucin Gene Expression by Interleukin (IL)-17 through IL-6 Paracrine/Autocrine Loop J. Biol. Chem., May 2, 2003; 278(19): 17036 - 17043. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. P. Paulsen, A. P. Corfield, M. Hinz, W. Hoffmann, U. Schaudig, A. B. Thale, and M. Berry Characterization of Mucins in Human Lacrimal Sac and Nasolacrimal Duct Invest. Ophthalmol. Vis. Sci., May 1, 2003; 44(5): 1807 - 1813. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Argueso, M. Balaram, S. Spurr-Michaud, H. T. Keutmann, M. R. Dana, and I. K. Gipson Decreased Levels of the Goblet Cell Mucin MUC5AC in Tears of Patients with Sjogren Syndrome Invest. Ophthalmol. Vis. Sci., April 1, 2002; 43(4): 1004 - 1011. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |